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Abstract
Injury-induced overexpression of tumor necrosis factor alpha (TNFa) in the spinal cord can induce chronic
neuroinflammation and excitotoxicity that ultimately undermines functional recovery. Here we investigate how TNFa
might also act to upset spinal function by modulating spinal plasticity. Using a model of instrumental learning in the injured
spinal cord, we have previously shown that peripheral intermittent stimulation can produce a plastic change in spinal
plasticity (metaplasticity), resulting in the prolonged inhibition of spinal learning. We hypothesized that spinal metaplasticity
may be mediated by TNFa. We found that intermittent stimulation increased protein levels in the spinal cord. Using
intrathecal pharmacological manipulations, we showed TNFa to be both necessary and sufficient for the long-term
inhibition of a spinal instrumental learning task. These effects were found to be dependent on glial production of TNFa and
involved downstream alterations in calcium-permeable AMPA receptors. These findings suggest a crucial role for glial TNFa
in undermining spinal learning, and demonstrate the therapeutic potential of inhibiting TNFa activity to rescue and restore
adaptive spinal plasticity to the injured spinal cord. TNFa modulation represents a novel therapeutic target for improving
rehabilitation after spinal cord injury.
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Introduction
The cytokine tumor necrosis factor alpha (TNFa) exerts a wide
range of neuromodulatory effects, from promoting neuroprotec-
tion to inducing apoptosis and excitotoxic cell death [1,2]. After
spinal cord injury (SCI), TNFa activity has been implicated as
a pathophysiological factor limiting behavioral recovery [3].
Overexpression of TNFa can induce neuropathic pain and
exacerbate excitotoxicity [4,5]. Recently, TNFa was shown to
mediate early excitotoxic cell death following spinal contusion
injury, and treatment with a TNFa inhibitor spared neurons and
improved function across a range of behavioral outcome [6].
TNFa also affects neural plasticity [7]. TNFa modulates
synaptic strength in vitro [8,9] and TNFa overexpression in the
hippocampus impairs spatial learning [10]. Recent work exploring
the role of TNFa in spinal plasticity has focused on changes in
nociceptive activity, showing that TNFa contributes to long-term
potentiation (LTP) of C-fiber evoked field potentials, and plays
a key role in the development of central sensitization [11,12]. The
capacity for the spinal cord to adapt and elicit altered behavioral
outcomes in response to stimuli (adaptive spinal plasticity) is
critical for functional recovery after injury, and understanding the
neurobiological agents undermining adaptive plasticity will be
essential for developing effective therapies [13,14]. To assay spinal
plasticity we used a high throughput in vivo assay of spinally-
mediated learning [15]. In this preparation, electrical stimulation
is delivered to the tibialis anterior muscle of a spinally-transected
rat when the ankle is in an extended, unflexed position
(controllable stimulation). Over time, the subject learns to keep
the ankle flexed, minimizing stimulus exposure [15]. The spinal
learning phenomenon provides an assay of adaptive spinal
plasticity that predicts functional recovery after spinal contusion
injury [16,17]. Subjects that receive intermittent electrical
stimulation independent of leg position (uncontrollable stimulation
to either the contralateral leg or the tail) later fail to learn when
tested with controllable stimulation [15]. Further work has shown
intermittent stimulation has a lasting effect on the capacity for
spinal learning and impairs recovery of function after spinal cord
injury [17,18].
We have shown that intermittent stimulation induces NMDA
and metabotropic glutamate receptor activation, downstream
protein kinase C activity, and requires de novo protein synthesis in
order to inhibit spinal learning [19–21]. These findings suggest
that intermittent stimulation is not inhibiting spinal learning by
simply blocking plasticity in the spinal cord, but instead reflects an
active process that modulates the capacity for subsequent plasticity
(measured by the spinal learning outcome).
We have previously shown that this form of intermittent
stimulation may undermine adaptive spinal learning by inducing
diffuse alterations in nociceptive plasticity [22]. We have shown
that intermittent stimulation produces bilateral tactile allodynia of
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that other noxious stimuli that are known to produce inflamma-
tion, such as intradermal capsaicin or carrageenan, also un-
dermine spinal instrumental learning [24]. Such findings suggest
that intermittent stimulation may elicit a diffuse, central sensiti-
zation-like effect. Further, intermittent stimulation given acutely
after contusion injury produces a long-term impairment in
behavioral recovery [17]. Thus, peripheral noxious input (likely
to accompany a natural spinal cord injury) may undermine
functional recovery by inducing an inhibition of adaptive spinal
plasticity. As uncontrolled nociceptive input is likely to accompany
spinal cord injury [25], it will be essential to determine the
biochemical mediators of maladaptive spinal plasticity in order to
tailor treatments that not only attenuate maladaptive plasticity, but
promote adaptive plasticity as well.
Here we tested the possible role of TNFa in the inhibition of
adaptive spinal learning. We found that intermittent stimulation
increases TNFa protein expression in the spinal cord. Intrathecal
TNFa administration produced a long-term inhibition of spinal
learning, and this effect required glial metabolism. Conversely,
treatment with a TNFa inhibitor blocked the induction of the
learning deficit produced by intermittent stimulation and rescued
spinal learning if given after the deficit was induced by intermittent
stimulation, TNFa, or a glial activator. Finally, we found the
effects of both TNFa and intermittent stimulation appear to be
mediated by calcium-permeable AMPA receptors, as treatment
with a specific antagonist rescued the capacity for spinal learning.
These findings highlight a critical role for TNFa in undermining
adaptive spinal plasticity, and suggest that TNFa inhibitors may
help rescue adaptive plasticity, providing a promising therapeutic
avenue for functional rehabilitation following SCI.
Methods
Animals
All experiments were carried out in accordance with NIH
standards for the care and use of laboratory animals (NIH
publications No. 80-23), and were approved by the University
Laboratory Animal Care Committee at Texas A&M University
(AUP #2009-161).
Male Sprague-Dawley rats obtained from Harlan (Houston,
TX) served as subjects. Rats were approximately 100–120 days old
and weighed between 360 and 460 g. They were housed
individually and maintained on a 12-hour light/dark cycle, with
all behavioral testing performed during the light cycle. Food and
water were available ad libitum.
Surgery
Subjects were anesthetized with 5% isoflurane. The 2
nd thoracic
vertebra (T2) was located by touch and a 2.5 cm anterior-posterior
incision was made over T2. The tissue immediately rostral to T2
was cleared, exposing the spinal cord. A thermal cautery was then
used to produce a complete transection of the cord, and the cavity
was then filled with Gelfoam (Harvard Apparatus, Holliston, MA).
A 25-cm polyethylene cannula (PE-10, VWR International,
Bristol, CT) was subsequently threaded 9 cm down the vertebral
column, into the subarachnoid space between the dura and the
white matter so that the cannula lay on the dorsal surface of the
spinal cord, over the L4-L5 spinal segments. The incision was
closed using Michel clips (Fine Science Tools Foster, CA), and the
exposed end of cannula tubing fixed to the skin with cyanoacry-
late.
Immediately following surgery, subjects received an injection of
0.9% saline (2.5 mL, i.p.). During recovery, the hindlimbs were
maintained in a normal flexed position using a piece of porous
orthaletic tape, wrapped gently around the rat’s body. The
recovery period was 24 hours, throughout which the rats were
housed in a temperature-regulated environment (25.5uC). Supple-
mental saline injections (0.9%, 2.5 mL, i.p.) were given daily to
ensure proper hydration, and bladders expressed twice daily, and
just before behavioral testing. Complete transections were
confirmed by a) visually inspecting the cord during surgery, b)
observing behavior following recovery, ensuring subjects exhibit
paralysis caudal to the site of transection, and do not vocalize
when shock is administered to the tail or hindpaw, c) examining
the transection site postmortem in a randomly selected subset of
subjects.
Drug Administration
Rat recombinant TNFa (R&D Systems, Minneapolis, MN) was
dissolved in phosphate-buffered saline (PBS) containing 0.1%
bovine serum albumin (BSA) at a concentration of 60 or 600 pg/
mL, delivered intrathecally in 10 mL. This dose response was based
on our previous work showing that intraparenchymal injection of
60 or 600 pg TNF-induced AMPA receptor trafficking [6]. In the
current experiments, the drug was administered intrathecally
rather than by direct nanoinjection into the spinal cord, thus we
increased the dose 10-fold to ensure bioavailability. Soluble TNF
receptor 1 (sTNFR1, R&D Systems, Minneapolis, MN), which
sequesters TNFa and reduces its endogenous activity, was
dissolved in PBS containing 0.1% BSA at a concentration of 35
or 70 ng/mL, and delivered intrathecally in 10 mL. sTNFR1
concentration was determined by starting with 100th of the dose
(3.5 mg) that has previously been found to attenuate neuropathic
pain when given intrathecally [26]. TNFa and sTNFR1 were
delivered by intrathecal injection in 10 mL. The glial metabolic
inhibitor fluorocitrate (Sigma-Aldrich, St. Louis, MO) was
dissolved in saline at a concentration of 4 nmol/mL and was
delivered by intrathecal injection in 1 mL. Fluorocitrate has been
previously shown to block the induction of a spinal learning deficit
induced by intermittent stimulation [27]. Lipopolysachharide
(LPS; Sigma-Aldrich, St. Louis, MO) was dissolved in saline at
a concentration of 10 mg/mL, and delivered by intrathecal
injection in 10 mL. This dose was chosen as it is been shown to
induce nociceptive activity as well as produce a lasting spinal
learning deficit [27,28]. The calcium-permeable AMPA receptor
antagonist 1- naphthyl acetyl spermine (Naspm) was dissolved in
saline and given at a concentration of 10 mM in 10 mL. This dose
has been shown to protect against ischemia-induced cell death in
the hippocampus [29,30]. All injections were followed by a 20 mL
saline flush.
Intermittent uncontrollable stimulation
Intermittent stimulation was administered while transected rats
were loosely restrained in opaque black Plexiglas tubes, 22 cm in
length and 6.8 cm in diameter. A flat floor constructed from
a sheet of black Plexiglas 5.5 cm wide was attached 5.3 cm below
the top of the tube. Electrical stimulation to the tail was delivered
using an electrode constructed from a modified fuse clip. The
electrode was coated with ECG gel (Harvard Apparatus,
Holliston, MA) and secured with porous tape approximately
6 cm behind the base of the tail (Figure 1A). Constant-current 1.5-
mA stimulation was delivered to the tail using a 660-V trans-
former. A Macintosh computer controlled the onset and offset of
stimulation. Each stimulation was 1.5 mA in intensity, 80 ms in
duration, delivered over the course of 6 minutes. The stimuli were
delivered intermittently in a randomized fashion between 0.2 and
3.8 seconds apart. Subjects received a single 6-minute session, over
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apart.
ELISA
TNFa levels were assessed using the TNFa immunoassay kit
from R&D Systems (Minneapolis, MN). Briefly, subjects were
deeply anesthetized with pentobarbital (50 mg/kg, i.p.) at one of
three timepoints: 20 minutes, 6 hours, or 24 hours after cessation
of stimulation. Spinal cords were harvested, flash-frozen in liquid
nitrogen, and stored at 280uC. Spinal tissue samples (1 cm in
length, L4-S2 spinal segments) were homogenized in cold lysis
buffer (phosphate-buffered saline, pH 7.4, with 1% Triton-X 100
and Roche Minicomplete protease inhibitor cocktail). Super-
natants were obtained by centrifugation (13,000 g for 15 min at
2uC) and stored at 280uC until assays were conducted according
to kit instructions. Absorbance was measured on a Victor 2
microplate reader (Perkin Elmer/Cetus, Norwalk, CT) and TNFa
concentrations were normalized to total protein determined with
the bicinchoninic acid (BCA) method.
Instrumental testing procedure
All subjects were allowed to recover for at least 24 h following
surgery and the hindlimbs were shaved and marked for electrode
placement prior to testing. Instrumental testing was conducted
while rats were loosely restrained in tubes (23.5 cm [length]68c m
[internal diameter]) (Figure 1B). Two slots in the tube, (5.6 cm
[length]61.8 cm [width]), 4 cm apart, 1.5 cm from the end of the
tube, allowed both hind legs to hang freely. To minimize the
effects of upper body movement on leg position, a wire belt was
secured to the rat’s trunk within the tube. Leg stimulation was
delivered using a BRS/LVE (Laurel, MD) constant current
(60 Hz, AC) shock generator (Model SG-903).
A wire electrode was inserted through the skin over the distal
portion of the tibialis anterior (1.5 cm from the plantar surface of
the foot), and one lead from the generator was attached to this
wire. A contact electrode (7 cm in length, 0.46 diameter, stainless
steel) was secured to the foot between the second and third digits
with a piece of porous tape. A fine wire (0.01 sq mm [36 AWG]
(20 cm) attached to the end of the contact electrode extended from
the rear of the foot and connected to a digital input monitored by
a Macintosh computer. A plastic rectangular dish (11.5 [w]619
[l]65 [d]) containing a salt solution was placed approximately
7.5 cm below the restraining tube. A drop of soap was added to
the solution to reduce surface tension. A ground wire was
connected to a 1 mm wide stainless steel rod, which was placed
in the solution. The shock generator was set to deliver a 0.4 mA
shock, and the proximal portion of the tibialis anterior (approx-
imately 1.7 cm proximal to the wire electrode) was probed with
a 2.5-cm stainless steel pin attached to a shock lead to find a robust
flexion response. The pin was then inserted 0.4 cm into the
muscle. A strain gauge was utilized to determine the amount of
shock necessary to elicit a 0.4 N flexion force, as this amount of
force has been shown previously to be ideal to produce the flexion
necessary for spinal instrumental learning [15].
To minimize lateral leg movements, a 20-cm piece of porous
tape was wrapped around the leg and attached to a bar extending
across the apparatus directly under the front panel of the
restraining tube. The tape was adjusted so that it was taut enough
to slightly extend the knee. Finally, three short (0.15 s) shock pulses
were applied and the level of the salt solution was adjusted so that
the tip of the contact electrode (attached to the rat’s foot) was
submerged 4 mm below the surface.
A rat’s capacity to perform the instrumental response was then
tested with exposure to 30 min of controllable shock. Whenever
the rat’s leg fell below the level of the salt solution, the electrodes
delivered a shock to the tibialis anterior muscle causing the ankle
to flex. Leg position was monitored using a Macintosh computer at
a sampling rate of 30 Hz.
Behavioral measures
Three behavioral measures, response number, response dura-
tion and time in solution, were used to assess a subject’s capacity to
perform the instrumental response [15]. Performance was
measured over time in 30 1-min time bins. The computer
monitoring leg position recorded an increase in response number
whenever the contact electrode was raised above the salt solution.
Response duration was derived from time in solution and response
number using the following equation: Response Duratio-
ni=(60 s2time in solutioni)/(Response Numberi+1) where i is
the current time bin.
Statistical Analyses
The ELISA experiment was cross-sectional; each post-stimula-
tion timepoint for spinal tissue collection was performed as an
Figure 1. An overview of stimulation modes used to affect spinal plasticity. A) Intermittent Stimulation. Six minutes of peripheral electrical
stimulation to the tail, that is not contingent upon leg position, is sufficient to induce a metaplastic inhibition of spinal instrumental learning. B)
Instrumental Testing. To test spinal learning, spinally transected subjects are given electrical stimulation that is contingent upon hindpaw position. If
the contact electrode is in contact with the salt solution, stimulation to the tibialis anterior muscle is delivered. Over time, subjects learn to keep the
ankle in a flexed position, increasing response duration and reducing net stimulation exposure. If subjects are given intermittent stimulation prior to
testing, spinal learning is inhibited.
doi:10.1371/journal.pone.0039751.g001
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compare unstimulated and intermittently-stimulated subjects at
each timepoint. All spinal learning experiments were run with
a balanced, full-factorial design and analyzed using mixed
ANOVAs with an a priori alpha value of p,0.05 considered
significant. This design allowed us to test the overall main effects of
drug/stimulation condition and time, as well as interactions
between these variables with a single general linear model (SPSS-
GLM, v.19). Significant interactions were followed up with one-
way ANOVAs on group means, which allowed for post hoc testing
(Duncan’s New Multiple Range). This analytic approach is
consistent with well-established standards within the statistical
literature [31].
Results
Intermittent stimulation increases TNFa protein
expression
To investigate the dynamics of stimulus-induced TNFa
expression, we assessed spinal TNFa protein expression after
intermittent stimulation. Although stimulation to the tail directly
drives sensory afferents in the sacral-coccygeal region, previous
work has shown that this stimulation also produces a diffuse effect
on more rostral spinal segments, as evidenced by the capacity for
intermittent tail stimulation to inhibit spinal learning, as well as
produce a tactile allodynia in the hindpaws [18,22,23]. As we have
previously shown that the essential anatomical locus for the
expression of the spinal learning effect lies in the L4-S2 region,
TNF protein expression was assessed in spinal cord blocks from
this region [32].
Spinally-transected rat subjects (n=6 subjects per group)
received either 6 minutes of intermittent stimulation or an
equivalent period of unstimulated restraint. Subjects were then
deeply anesthetized with pentobarbital (50 mg/kg, i.p.) at one of
three timepoints after treatment: 20 minutes, 6 hours, or
24 hours. As before, spinal cord sections (L4-S2) were removed,
flash-frozen with liquid nitrogen, and stored at 280uC. Tissue was
then subsequently homogenized and processed for assessment with
enzyme-linked immunosorbent assay (ELISA) as described in the
Methods section.
The effect of intermittent stimulation on TNFa protein
expression is depicted in Figure 2. TNFa protein expression was
unchanged for unstimulated controls across timepoints. Planned
comparisons were performed at each time point revealing that
TNFa protein expression after intermittent stimulation was
significant at 24 hours [F(1, 10)=6.49, p,.05], but not at
20 minutes or 6 hours.
Intermittent stimulation-induced inhibition of spinal
learning requires endogenous TNFa activity
As the previous experiments showed that intermittent stimula-
tion can induce an increase in TNFa protein expression, the
current experiment was designed to test whether endogenous
TNFa activity is necessary in order for intermittent stimulation to
undermine future spinal learning. Twenty-four hours after
complete transection, subjects (n=8 per group) received an
intrathecal injection of either soluble TNF receptor sTNFR1
(350 ng), which acts to inhibit TNFa activity by sequestering
endogenous soluble TNFa, or vehicle (PBS+0.1% BSA). Forty-five
minutes later, subjects received either 6 minutes of intermittent
stimulation or an equivalent period of unstimulated restraint. All
subjects were then immediately tested for spinal instrumental
learning.
As expected, vehicle-treated unstimulated subjects exhibited an
increase in response duration over the testing session, indicative of
spinal learning (Fig. 3A). Likewise, subjects that received the
TNFa inhibitor sTNFR1 alone were able to learn. Vehicle-treated
subjects that received intermittent stimulation exhibited a pro-
nounced learning deficit. Interestingly, those subjects that received
the TNFa inhibitor prior to intermittent stimulation exhibited no
learning deficit. An ANOVA revealed a main effect of time
[F(29,812)=7.58] and a significant three-way interaction between
time, drug, and stimulation, F(29, 812)=1.54, p,.05. This in-
teraction indicates that learning (the adaptive change in flexion
duration over time) is dependent on both stimulation condition and
TNFa inhibitor treatment. No other effects were significant,
p..05.
To evaluate whether our experimental treatment affected
baseline behavioral reactivity, we analyzed both the shock intensity
required to elicit a flexion force of 0.4 N and the duration of the
first shock-elicited flexion response. Independent analyses of
variance (ANOVAs) showed that there were no group differences
on either measure, Fs,2.58, p,0.05. We found no significant
differences on these measures in any of the subsequent spinal
learning experiments, therefore those data are not shown.
The number of responses made by each subject was also
assessed (Figure 3B). On average, subjects that exhibited the
learning deficit exhibited the highest rate of responding, while
those that learned responded less frequently. The difference in
total response number was assessed using an ANOVA, revealing
main effects of drug [F(1, 28)=6.81], stimulation [F(1, 28)=4.74],
and time [F(29, 812)=3.82], as well as significant Drug X
Stimulation [F(1, 28)=5.53], Time X Drug [F(29, 812)=3.90], and
Time X Drug X Stimulation interactions [F(29, 812)=2.02], p,.05.
Post hoc analysis of group means showed that vehicle-treated
subjects receiving intermittent stimulation were significantly
different from all other groups, p,.05. This pattern of results is
similar to that reported in prior studies [15,18] and emerges
because rats that fail to learn respond in a mechanical manner to
stimulation. For these subjects, stimulation elicits a flexion re-
sponse, but does not produce an increase in flexion duration (our
index of learning). This observation is important because it
demonstrates that the inhibition of learning does not reflect an
inability to perform the target response (i.e., a performance deficit).
Figure 2. Intermittent stimulation increases TNFa protein
expression. ELISA data are presented as mean TNFa protein
expression; variability is expressed as SEM. Intermittent stimulation
produced an increase in TNFa protein culminating in a significant
increase over unstimulated control subjects at 24 hours. Asterisk
signifies statistical significance, p,.05.
doi:10.1371/journal.pone.0039751.g002
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relationship between response duration and response number, and
because the former measure provides an index of learning that
avoids some interpretative problems [15], we only report response
duration in subsequent experiments.
Endogenous TNFa affects both induction and expression
of the stimulation-induced inhibition of spinal learning
The prior experiment showed that pretreatment with a TNFa
inhibitor prior to intermittent stimulation blocked the learning
deficit when subjects were tested immediately, i.e. while the drug
was still effective. Expanding on that finding, the current
experiment examined the long-term effect of a TNFa inhibitor
when given either prior to intermittent stimulation or prior to
testing. In this way, the current experiment tests whether
endogenous TNFa is necessary for intermittent stimulation to
induce the spinal learning deficit, as well as tests the possibility that
TNFa is necessary in order for the learning deficit to be expressed
following intermittent stimulation.
The design of this experiment is depicted in Figure 4. All
subjects were given complete transections at T2 24 hours before
experimental manipulation began. To test the long-term effect of
intermittent stimulation, two groups (n=8 subjects per group)
were given vehicle injections, followed 45 minutes later with either
6 minutes of intermittent stimulation or an equivalent period of
unstimulated restraint. Twenty-four hours later, subjects were
given a second vehicle injection, followed by instrumental testing.
To test the effect of TNFa inhibition on the induction of the spinal
learning deficit, two groups (n=8 subjects per group) were given
sTNFR1 (350 ng), followed 45 minutes later with 6 minutes of
intermittent stimulation or an equivalent period of unstimulated
restraint. Twenty-four hours later, subjects were given a vehicle
injection, followed by instrumental testing. Finally, to test the effect
of TNFa inhibition on the expression of the learning deficit, two
groups (n=8 subjects per group) were first given vehicle injections,
followed 45 minutes later with 6 minutes of intermittent stimula-
tion or an equivalent period of unstimulated restraint. Twenty-
four hours later, subjects received an intrathecal injection of
sTNFR1, followed by instrumental testing. This design allowed us
to: a) verify that treatment with intermittent stimulation inhibits
spinal learning 24 hours later, b) test whether sTNFR1 before
intermittent stimulation blocks the induction of the learning deficit,
and c) test whether sTNFR1 after intermittent stimulation blocks
the expression of the learning deficit. The design of this experiment
allowed for the same stimulated and unstimulated vehicle-treated
controls to be compared to both the induction and expression
groups in the subsequent analyses.
Figure 3. Blocking endogenous TNFa activity prior to intermittent stimulation protects against the inhibition of spinal learning.
Subjects received intrathecal injection of either 350 ng of the TNFa inhibitor sTNFR1 or vehicle, followed by 6 minutes of intermittent electrical
stimulation (Stimulated) or none (Unstimulated). All subjects were then immediately tested for instrumental learning. A) Left panel depicts response
durations over time. Increased response durations over time are indicative of spinal instrumental learning. Right panel depicts mean response
durations for each group, collapsed over time. Error bars represent SEM for group means. B) Left panel depicts response number over time. Right
panel depicts mean response number for each group. Data show that subjects who failed to learn had higher response numbers, confirming that
these subjects are not exhibiting a deficit in response performance. Shaded areas represent SEM over time; error bars represent SEM for group means.
doi:10.1371/journal.pone.0039751.g003
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spinal learning in vehicle-treated subjects (Figure 5A). The effect of
TNFa inhibition on the induction of the stimulus-induced learning
deficit is depicted in Figure 5B. Subjects that received the TNFa
inhibitor prior to intermittent stimulation exhibited no learning
deficit. An ANOVA comparing these subjects to the vehicle
controls revealed main effects of drug [F(1, 28)=4.24], stimulation
condition [F(1,28)=6.84], and time [F(29, 812)=3.45], p,.05.
Further, the Time X Stimulation interaction [F(29, 812)=1.67]
and the Time X Drug X Stimulation interaction [F(29, 812)=2.38]
were both significant, p,.05. Post hoc comparison of the group
means confirmed that the vehicle-treated intermittent stimulated
group differed significantly from all other groups, p,.05. No other
effects were significant, p..05.
The effect of TNFa inhibition on the expression of the stimulus-
induced spinal learning deficit is depicted in Figure 5C. As in the
induction groups, those that received sTNFR1 alone had no
impairment in learning. Surprisingly, those that received sTNFR1
following intermittent stimulation were also able to learn. An
ANOVA comparing these groups to the vehicle controls revealed
a significant main effect of trials [F(29, 812)=3.51], as well as
a significant Time X Stimulation interaction, [F(29, 812)=2.30],
p,.01. Post hoc comparison of the group means confirmed that the
vehicle –treated group that received intermittent stimulation
differed significantly from all other groups, p,.05. No other
effects were significant, p..05.
The protective effect of TNFa inhibition found in the induction
groups of this experiment extends the findings from the previous
experiment, in which sTNFR1 was shown to protect against the
stimulation-induced learning deficit when subjects were tested
immediately following intermittent stimulation. Here, this pro-
tective effect was evident when subjects were tested 24 hours after
intermittent stimulation.
Beyond the protective effect of TNFa inhibition, this experi-
ment also demonstrates that sTNFR1 can provide a therapeutic
effect, blocking the expression of the stimulation-induced learning
deficit when given 24 hours after intermittent stimulation. That
learning can be rescued by blocking TNFa activity suggests that
the role for TNFa in the inhibition of spinal learning is not
a transient one; rather, the capacity for TNFa inhibition to restore
learning long after the deficit has been induced suggests that
intermittent stimulation may not only cause TNFa release, but
that this release may be sustained.
Spinal administration of exogenous TNFa generates
a long-term inhibition of spinal learning
It has been shown that the overexpression of TNFa can lead to
a robust increase in neural excitability that ultimately undermines
learning [10]. Similarly, a number of pharmacological agents that
are known to induce the spinal learning deficit have been
correlated with increased TNFa release [33–35]. Here we tested
whether administration of exogenous TNFa can substitute for
intermittent stimulation to produce a spinal learning deficit.
Twenty-four hours after complete transection, subjects (n=8
per group) received an intrathecal injection of one of two doses of
TNFa (600 or 6000 pg) or vehicle (PBS+0.1% BSA). Subjects were
then tested for instrumental learning either 45 minutes after
injection, or 24 hours after injection.
As expected, vehicle-treated subjects were able to learn
(Figure 6). Those that received the highest dose of TNFa
(6000 pg), either 45 minutes or 24 hours prior to testing, exhibited
a learning deficit (Figure 6A & B). An ANOVA revealed main
effects of drug treatment [F(2, 42)=6.96] and time [F(29,
1218)=4.78], as well as a significant Drug X Time interaction
[F(58, 1218)=1.38], p,.05. Post hoc analyses of the group means also
showed a significant difference between the highest dose of TNFa
and vehicle, at both the immediate and 24 hour time points,
p,.05. No other effects were significant, p..05.
The previous two experiments demonstrated that endogenous
TNFa was necessary to produce a stimulus-induced spinal
learning deficit. Here we expand on those findings by showing
that administration of TNFa is also sufficient to produce both
acute and long-term inhibition of spinal learning. The highest
doses tested at either timepoint caused a deficit that is
commensurate with the level of impairment seen in intermittent-
ly-stimulated subjects, lending further evidence that TNFa activity
may mediate the stimulus-induced inhibition of spinal learning.
TNFa inhibition prior to testing restores the capacity for
spinal learning
Prior work has shown that TNFa administration can lead to an
increased expression of endogenous TNFa stores [36]. Such
sustained TNFa activity could mediate the long-term TNFa-
induced learning deficit that was observed in the previous
experiment. The current experiment was designed to address this
possibility, assessing whether the long-term spinal learning deficit
Figure 4. Experimental design for Experiment 2. Twenty-four hours after complete transection, all subjects were given a first injection of either
sTNFR1 (350 ng) or vehicle, followed by either intermittent stimulation or nothing, and then 24 hours later, received a second injection of either
sTNFR1 (350 ng) or vehicle. All subjects were then tested for instrumental learning. Subjects were divided into three groups; Control, in which they
received vehicle at both injection timepoints; Induction, in which they received sTNFR1 prior to intermittent stimulation (or no stimulation); and
Expression, in which they received sTNFR1 24 hours after intermittent stimulation (or no stimulation).
doi:10.1371/journal.pone.0039751.g004
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activity prior to testing.
Twenty-four hours after complete transection, subjects (n=8
per group) received an intrathecal injection of TNFa (6000 pg) or
vehicle (PBS+0.1% BSA). Twenty-fours later, subjects were given
the TNFa inhibitor sTNFR1 or vehicle 45 minutes prior to
testing. Because pilot data indicated a 350 ng dose of sTNFR1 had
a partial effect, two additional groups were added that were
treated with a higher dose (700 ng) of sTNFR1 prior to testing.
As expected, subjects that received only vehicle injections were
able to learn (Figure 7A). Vehicle-treated subjects that received
sTNFR1, at either dose, also learned. Subjects given TNFa alone
exhibited a learning deficit when tested 24 hours later, replicating
the finding from the previous experiment (Figure 7B). Interest-
ingly, TNFa-treated subjects that were given sTNFR1 prior to
testing exhibited no learning deficit. An ANOVA revealed
a significant main effect of both TNFa treatment and time,
F.6.75, p,.05. Although no other main effects or interactions
were significant, the interaction between TNFa treatment and
sTNFR1 treatment approached significance, F (2,42)=3.13,
p=.054. To further explore this relationship, trend analyses were
run. These analyses revealed that the linear component of the
Time X TNF X sTNFR1 interaction was significant, F=10.42,
p,.01. The trend analyses also showed that the quadratic
component of the Time X sTNFR1 interaction to be significant,
F=5.81, p,.05. Finally, a post hoc comparison of the group means
revealed that the group that received TNFa alone differed
significantly from all other groups, p,.05 (Figure 7C). This
finding suggests that TNFa activity is still required 24 hours after
TNFa treatment in order for the learning deficit to be expressed,
and lends evidence for the possibility that exogenous TNFa
administration may elicit an increased expression of endogenous
TNFa that outlasts the initial treatment.
Inhibition of glial metabolism blocks TNF-induced
inhibition of spinal learning
TNFa is known to be released primarily from glial cells. Kuno
et al. (2005) demonstrated that administration of exogenous TNFa
to cultured microglia could induce the sustained production and
release of endogenous TNFa [36]. Thus, if TNFa underlies the
long-term effect of intermittent stimulation by inducing further
TNFa expression, then the maintenance (memory) of that effect
should depend on glial activity. Supporting this, Vichaya et al.
(2009) have shown that the glial metabolic inhibitor fluorocitrate
given prior to intermittent stimulation blocked the induction of the
spinal learning deficit [27]. The current experiment explored
whether the administration of fluorocitrate prior to TNFa
treatment would block the long-term effect of TNFa on spinal
learning.
Twenty-four hours after complete transection, subjects (n=6
per group) received an intrathecal injection of either the glial
inhibitor fluorocitrate (4 nmol) or saline vehicle. Forty-five minutes
Figure 5. Inhibition of endogenous TNFa blocks the induction and expression of the inhibition of spinal learning. A) Vehicle Controls.
Response durations increased over time for those that did not receive intermittent stimulation (Unshocked), while those that did receive intermittent
stimulation (Shocked) exhibited a learning deficit. These groups were used to compare to the Induction and Expression experimental groups. B)
Induction. Response durations increased over time for both groups, indicating that sTNFR1 blocked intermittent stimulation from inducing a spinal
learning deficit. C) Expression. Response durations increased over time for both groups, indicating that sTNFR1 blocked the expression of the
intermittent stimulation-induced learning deficit. D) Group means collapsed over time. The group that received intermittent stimulation in the
absence of sTNFR1 had significantly lower response durations over time than all other groups. Shaded areas represent SEM over time; error bars
indicate SEM for group means. Asterisk signifies statistical significance, p,.05.
doi:10.1371/journal.pone.0039751.g005
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were then tested for instrumental learning 24 hours later.
Subjects that only received vehicle treatment were able to learn
as expected (Figure 8). Likewise, those subjects that received
fluorocitrate alone also learned, replicating prior findings [27].
Subjects receiving TNFa alone exhibited a marked learning
deficit, and interestingly, this effect was blocked in subjects that
received fluorocitrate prior to TNFa treatment. An ANOVA
revealed a significant interaction between drug treatments,
F(1,20)=6.30, p,.05. There was a significant main effect of time
[F(29, 580)=2.00], as well as a significant interaction between time,
TNFa, and fluorocitrate treatment, F(29, 580)=1.62, p,.05. Post hoc
analysis of group means showed that subjects receiving TNFa
alone differed significantly from those that received vehicle alone,
as well as those who received fluorocitrate prior to TNFa
treatment, p,.05. No other differences approached significance,
p..05. This experiment demonstrates the necessity for glial
metabolism in order for TNFa treatment to produce a long-term
spinal learning deficit, and provides evidence that exogenous
TNFa treatment may lead to sustained glial release of endogenous
TNFa.
TNFa inhibition prior to testing reverses the inhibition of
spinal learning induced by glial activation
The previous experiments have shown TNFa to be sufficient to
produce a long-term inhibition of spinal learning, and that glial
activation is necessary to produce this effect. Lipopolysaccharide
(LPS) is a bacterially-derived endotoxin that is most often used to
experimentally challenge the immune system. LPS binds the toll-
like receptor 4 (TLR4) on macrophages (and microglia) activating
these cells. The LPS-glial interaction produces a host of biological
consequences: inducing histamine release, vasodilation, activation
of blood coagulating factors, as well as the release of a host of
inflammatory cytokines, including TNF [37]. Prior work has also
shown that LPS is sufficient to undermine spinal learning [38].
Despite the varied effects of LPS, the present experiment was
designed to test the specific contribution of LPS-induced glial
Figure 6. Administration of exogenous TNFa generates immediate and lasting metaplastic inhibition of spinal learning. A) Subjects
received an intrathecal injection of 600 pg TNFa, 6000 pg TNFa, or vehicle. All groups were then tested for spinal instrumental learning. Left panel
depicts response durations over time. TNFa administration undermined spinal learning in a dose-dependent fashion. Shaded area represents SEM
over time. Right panel shows group response duration means collapsed over time. The group that received the highest dose of TNFa differed
significantly from the vehicle-treated group. Error bars represent SEM for the group means. Asterisk signifies statistical significance, p,.05. B) Subjects
received an intrathecal injection of 600 pg TNFa, 6000 pg TNFa, or vehicle 24 hours prior to instrumental testing. Left panel depicts response
durations over time. TNFa administration undermined spinal learning in a dose-dependent fashion. Right panel shows group response duration
means collapsed over time. The group that received the highest dose of TNFa differed significantly from the vehicle-treated group. Shaded areas
represent SEM over time; error bars indicate SEM for group means. Asterisk signifies statistical significance, p,.05.
doi:10.1371/journal.pone.0039751.g006
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TNFa (6000 pg) or vehicle, followed 24 hours later by an injection of 350 ng sTNFR1, 700 ng sTNFR1, or vehicle. All subjects were then tested for
instrumental learning. A) Vehicle controls. Subjects that did not receive a TNFa injection exhibited increased response durations over time, indicative
of spinal instrumental learning. B) Of those that received TNFa injections, those treated with either 350 ng or 700 ng sTNFR1 24 hours later were able
to exhibit an increase in response duration over time. C) Group response duration means collapsed over time. Those that received TNFa alone had
significantly lower response durations than all other groups. Shaded areas represent SEM over time; error bars indicate SEM for group means. Asterisk
signifies statistical significance, p,.05.
doi:10.1371/journal.pone.0039751.g007
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administration, in order to further investigate the natural
interaction between glial activation, TNFa release, and the
expression of the spinal learning deficit.
Twenty-four hours after complete transection, subjects (n=6
per group) were given an intrathecal injection of either 100 mg
LPS or vehicle. This dose of LPS has been used previously to
induce a spinal learning deficit [38]. Twenty-four hours later,
subjects were administered an intrathecal injection of either
sTNFR1 (700 ng) or vehicle. All subjects were then tested for
instrumental learning.
Subjects that received sTNFR1 or vehicle alone were able to
learn (Figure 9). As expected, subjects receiving LPS alone
exhibited a robust learning deficit. Interestingly, subjects that
received sTNFR1 24 hours after LPS treatment were able to
learn. An ANOVA revealed main effects of LPS treatment [F(1,
28)=12.61], sTNFR1 treatment [F(1, 28)=4.74, and time [F(29,
812)=4.97], p,.05. Likewise, there were significant LPS X
sTNFR1 [F(1, 28)=5.88] and Time X LPS interactions [F(29,
812)=1.82], p,.05. Post hoc analysis of group means confirmed that
the group receiving LPS alone was significantly different than all
others, p,.05. No other effects were significant, p..05. As LPS
has been shown to induce glial activation and glial release of
TNFa, this finding suggests that LPS-induced inhibition of spinal
learning may be mediated by glial TNFa. The finding that TNFa
inhibition blocked the expression of the spinal learning deficit
when given 24 hours after LPS treatment also lends further
evidence to the notion that TNFa undermines adaptive plasticity
through sustained activity, rather than inducing an immutable
change in neural functioning or synaptic strength.
Inhibition of spinal learning engages calcium-permeable
AMPA receptors
Having shown TNFa to be a necessary and sufficient
component in the inhibition of spinal learning, we were also
interested in how TNFa may engage downstream processes to
manifest this behavioral effect. Previous research has shown that
neuronal TNFa receptor activation causes an increase in
membrane trafficking of GluR2-lacking AMPA receptors [39].
Unlike AMPA receptors that express the GluR2 subunit, these
receptors are calcium-permeable. This permeability allows for
a substantial increase in postsynaptic excitability, and with
sufficient stimulation, can lead to excitotoxicity. This phenomenon
has recently been shown to underlie cell death following SCI [6].
The current experiment assessed whether the spinal learning
deficit (induced by either intermittent stimulation or TNFa
treatment) engages calcium-permeable AMPA receptors.
Twenty-four hours after complete transection, subjects (n=10
per group) were given one of three initial treatments: either an
intrathecal injection of TNFa (6000 pg), intrathecal injection of
saline vehicle, or 6 minutes of intermittent stimulation. Twenty-
four hours later, all subjects were given a secondary treatment:
intrathecal injection of either the GluR2-lacking AMPA receptor
antagonist Naspm (10 mM) or vehicle. Naspm at this dose has
been shown to attenuate ischemia-induced cell death in the
hippocampus [29,30]. All subjects were then tested for in-
strumental learning. This design allowed for vehicle control
subjects to be compared to both TNFa -treated and stimulated
experimental groups. As such, these comparisons were analyzed
separately.
As expected, those subjects that received either vehicle or
Naspm alone were able to learn (Figure 10A). Likewise,
stimulation-treated subjects that received a secondary vehicle
treatment failed to learn (Figure 10B). Interestingly, those that
received Naspm after intermittent stimulation did not exhibit
a learning deficit. When comparing these groups, ANOVA
revealed main effects of intermittent stimulation treatment [F(1,
36)=7.39], and time [F(29, 1015)=5.89], p,.05. There was also
a significant Stimulation X Naspm interaction [F(1, 36)=4.16] and
Time X Stimulation interaction, F(29, 1044)=1.60, p,.05. Post hoc
analysis of group means confirmed that the stimulation-treated
group that received secondary vehicle treatment differed signifi-
cantly from the other groups, p,.05.
Similar to the stimulation-treated subjects, those that received
an initial TNFa treatment followed by vehicle were unable to
learn, while those that received Naspm after TNFa treatment did
not exhibit a learning deficit (Figure 10C). When comparing these
two groups to vehicle controls, an ANOVA revealed main effects
Figure 8. TNF-induced inhibition of spinal learning requires glial metabolism. Subjects received an intrathecal injection of either the glial
metabolic inhibitor fluorocitrate (4 nmol) or vehicle, followed by either TNFa (6000 pg) or vehicle. All subjects were then tested for instrumental
learning 24 hours later. Left panel depicts response durations over time. Those that did not receive TNFa were able to exhibit increased response
durations over time. Those that received fluorocitrate prior to TNFa were also able to learn. Right panel shows group response durations collapsed
over time. The group that received TNFa alone differed significantly from vehicle controls, as well those that received fluorocitrate prior to TNFa.
Shaded areas represent SEM over time; error bars indicate SEM for group means. Asterisk signifies statistical significance, p,.05.
doi:10.1371/journal.pone.0039751.g008
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PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e39751Figure 9. Glial activation generates a lasting inhibition of spinal learning that is reversed by TNFa inhibition. Subjects received an
intrathecal injection of the potent glial activator lipopolysaccharide (LPS; 100 mg) or vehicle. Twenty-four hours later, subjects received either sTNFR1
(700 ng) or vehicle, followed by testing for instrumental learning. Left panel depicts response duration over time. LPS treatment alone caused a deficit
in spinal learning, while sTNFR1 treatment after LPS allowed for increased response durations over time. Right panel shows group response durations
collapsed over time. Subjects that received LPS alone differed significantly from all other groups. Shaded areas represent SEM over time; error bars
indicate SEM for group means. Asterisk signifies statistical significance, p,.05.
doi:10.1371/journal.pone.0039751.g009
Figure 10. Stimulus- and TNFa -induced inhibition of spinal learning requires calcium-permeable AMPA receptor activity. Subjects
received an initial treatment of vehicle, TNFa, or intermittent shock, followed 24 hours later by a secondary treatment of either vehicle or the calcium-
permeable AMPA receptor antagonist Naspm. All subjects were then tested for spinal instrumental learning. A) Control Groups. Subjects that
received initial vehicle injections were able to learn, regardless of secondary treatment. B) Intermittent Stimulation. Initial treatment with intermittent
stimulation produced a learning deficit in those subjects that received vehicle as their secondary treatment. In contrast, those that received Naspm
were able to learn significantly better than those that received vehicle. C) TNFa. Initial treatment with TNFa produced a learning deficit in those
subjects that received vehicle as their secondary treatment. In contrast, those that received Naspm were able to learn significantly better than those
that received vehicle. D) Group means, collapsed across time. Shaded areas represent SEM over time; error bars indicate SEM for group means.
Asterisk signifies statistical significance, p,.05.
doi:10.1371/journal.pone.0039751.g010
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a significant interaction between the two [F(29, 1044)=1.66], p,.05.
There was also a marginally significant interaction between TNFa
and Naspm treatment, F(1,36)=4.08, p=.05. Post hoc analysis of
group means confirmed that the TNFa -treated group that
received secondary vehicle treatment performed worse than
Naspm-treated, or double-vehicle groups, p,.05. These findings
suggest a necessary role for calcium-permeable AMPA receptors in
the inhibition of spinal learning, and suggest a common mecha-
nism of action between intermittent stimulation and TNFa in
producing this effect.
Discussion
The present findings demonstrate that TNFa is necessary and
sufficient for generating lasting inhibition of spinal learning in our
instrumental learning paradigm. We found that the long-term
inhibition of spinal learning induced by TNFa administration
required glial metabolism, and could be reversed by a TNFa
inhibitor given prior to testing. Taken together, these findings
suggest a critical role for glial TNFa in undermining spinal
learning, and demonstrate the therapeutic potential for TNFa
inhibitors in restoring the capacity for adaptive spinal plasticity.
We used a simple model of spinal instrumental learning to assess
the effect of TNFa on spinal plasticity. This model is unique in
that it allows for pharmacological and physiological manipulations
of the isolated spinal cord, while providing a behavioral measure of
spinal plasticity. Further, the findings from this paradigm translate
well to more naturalistic SCI preparations such as recovery in
spinal cord contusion and stepping in chronic transection,
providing clinical relevance to these pursuits [13,17,40].
One concern with testing the role of TNFa in spinal
instrumental learning is that the transection injury used in this
model could potentially alter baseline TNFa levels in the essential
spinal circuitry where spinal learning takes place. Studies of the
expression profile of TNFa following spinal cord injury have
shown that TNFa peaks around 1 hour after injury, and then
slowly fades over the next 48–72 hours [41]. Given these findings,
and the fact that subjects in the current experiments were allowed
to recover for 24 hours following complete transection, it is likely
that any injury-induced changes in TNFa expression caudal to the
transection site have returned to baseline by the time of testing.
Further, having shown that unstimulated control subjects are able
to exhibit spinal instrumental learning, the TNF levels in these
subjects is clearly too low to affect the acquisition of this learning
response.
Metaplasticity in the Spinal Cord
In 1982, Cooper and colleagues introduced a mathematical
theory to describe how synaptic strength is informed by prior
experience (BCM theory) [42]. They described a ‘‘modification
threshold’’ that is raised or lowered as a result of experience,
producing an alteration in susceptibility to future plasticity. In
effect, this phenomenon describes the plasticity of plasticity, or as
later termed, ‘‘metaplasticity’’ [43].
In a series of studies on ocular dominance plasticity, Bear and
others demonstrated a behavioral correlate for the theoretical
framework laid by Cooper and colleagues [44]. They showed that
in response to a period of monocular deprivation, synaptic
strength in the contralateral visual cortex was weakened while
responses in the ipsilateral visual cortex were strengthened [44,45].
Thus, prior exposure to monocular deprivation produced a meta-
plastic effect on future synaptic strength. Others have linked
metaplasticity to the release of neuromodulators, such as substance
P and 5HT, which have been shown to affect the induction and
expression of plasticity in spinal cord interneurons, eliciting
metaplastic effects and long-term synaptic reorganization within
lamprey locomotor networks [46,47].
Here, and in previous experiments, we have expanded the view
of metaplasticity to include measures of behavioral output from
the spinal cord [19]. As in the example of ocular dominance
plasticity, prior exposure to a stimulus (intermittent stimulation)
produces a lasting change in future plasticity (in this case, an
inhibition of spinal learning). It is not clear whether this alteration
reflects a shift in modification threshold, or perhaps a biological
switch, that inhibits spinal learning. Previous data do suggest
though, that this effect does not reflect a general inhibition of
spinal function. Indeed, at the same time spinal learning is
inhibited, reactivity to mechanical stimulation is enhanced
(allodynia) [22]. Intermittent stimulation engages a form of
plasticity, the expression of which affects whether a selective
response modification (spinal learning) can occur. Similar to the
metaplastic effect in ocular dominance, we have shown that the
stimulation-induced spinal learning deficit is an active process,
modulated by NMDA receptor function [20,22,48,49]. We have
shown that treatment with a NMDA receptor antagonist (MK-
801) prior to intermittent stimulation will block the induction of
the learning deficit [22]. Further, similar to the metaplastic effects
seen in the lamprey spinal cord model, we have shown that the
stimulation-induced inhibition of spinal learning reflects altera-
tions in group I metabotropic glutamate receptor activation,
downstream protein kinase C activity, and requires de novo protein
synthesis [19,21,46,47]. Importantly, the stimulus-induced impair-
ment in spinal learning is not immutable; the effect of intermittent
stimulation decays over time and can be reversed by both
behavioral and pharmacological treatments [18,23,50]. These
observations suggest that intermittent stimulation has a general
modulatory effect on plasticity, and as it alters the capacity for the
future expression of other forms of plasticity (spinal learning), it
can be characterized as a form of spinal metaplasticity.
Possible Mechanisms of Action
While we have demonstrated that TNFa is necessary and
sufficient to produce the inhibition of spinal learning in this
paradigm, the question remains as to how TNFa might be
exerting this metaplastic effect. Prior work has characterized the
spinal learning deficit as reflecting a diffuse overexcitation of spinal
neurons, producing a saturation effect that stifles the capacity for
future learning [16,19,24]. The current findings support this view,
as the excitatory effects of TNFa have been widely demonstrated.
TNFa receptor (TNFR1) activation has been shown to increase
neural excitability by directly, and indirectly, affecting ion
channels through a number of distinct intracellular pathways.
Using cultured hippocampal slices, Furukawa and Mattson (1998)
observed a significant increase in current through L-type calcium
channels following long-term incubation with TNFa [51]. This
effect was dependent upon TNFR1 activation of the downstream
transcription factor nuclear factor-kappa B (NF-kB). TNFa
application has also been shown to rapidly enhance currents in
tetrodotoxin-resistant Na+ channels, leading to acute mechanical
sensitization [52]. Interestingly, this effect was mediated by
a TNFR1-dependent phosphorylation of p38 MAPK. Coupled
with the necessity for this kinase in the glial release of TNFa, this
finding suggests a potentially critical role for p38 MAPK in both
the neural and glial effects of TNFa [53].
Despite having some direct effects on excitability through ion
channels, TNFa has been more widely characterized by its
capacity to indirectly affect synaptic strength by modulating
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demonstrated that glial TNFa acts to increase trafficking of AMPA
receptors to the post-synaptic membrane [8]. As such, TNFa-
induced AMPA receptor trafficking can potentiate excitotoxicity
[4]. Stellwagen et al. refined the view of this phenomenon by
illustrating that TNFR1 acts upon the phosphatidylinositol 3-
kinase (PI3K) pathway to mediate the trafficking of calcium-
permeable AMPA receptors [39]. Further, TNF-mediated traf-
ficking of calcium-permeable AMPA receptors has recently been
shown to undermine neural function following SCI [6]. In the
present study, we found that specific antagonism of this receptor
type rescued the capacity for spinal learning after both TNFa and
intermittent stimulation. As high levels of calcium-permeable
AMPA receptor activation are known to promote overexcitation,
this finding also supports the idea that metaplastic inhibition of
spinal learning may reflect a modulatory effect that resembles
saturation. Thus, blocking these receptors appears to return the
neural environment to a more quiescent state in which an adaptive
modification such as spinal learning can occur.
In contrast to the deleterious effects of TNFa on spinal learning,
we have also found a number of beneficial effects of training with
contingent stimulation. Although intermittent non-contingent
(uncontrollable) stimulation can induce a lasting impairment in
spinal learning, exposure to either regularly-spaced or response
contingent (controllable) stimulation can induce a lasting facilita-
tion of spinal learning [18,54]. We have recently shown a necessary
and sufficient role for brain-derived neurotrophic factor (BDNF) in
mediating these positive effects [23,54]. BDNF treatment can
protect against the stimulation-induced spinal learning deficit, as
well as rescue learning after the deficit has been induced.
Interestingly, TNFa and BDNF have been shown to play opposite
roles in synaptic scaling [55]. The opposing effects of these two
agents suggests a possible constitutive balance between TNFa and
BDNF, and tipping one or the other toward overexpression may
be key in shifting spinal metaplasticity between adaptive and
maladaptive outcomes.
We demonstrated that intrathecal TNFa treatment is sufficient
to produce a spinal learning deficit when given immediately prior
to testing, and interestingly, 24 hours prior to testing. As discussed
above, TNFa can engage a number of excitatory pathways that
could be responsible for the long-term deficit. Interestingly, we
found that inhibiting TNFa activity prior to testing blocked the
long-term TNFa-induced learning deficit. This finding suggests
that sustained TNFa activity is necessary in order for the deficit to
be expressed. From this perspective, TNFa can be thought to act
in one of two ways: either the exogenous TNFa is continuing to
activate TNF receptors 24 hours after administration, or the
administered TNFa is inducing the release of endogenous TNFa
stores. Though acute TNFa administration has not yet been
shown to directly elicit sustained TNF receptor activation, the
capacity for TNFa to stimulate the glial production and release of
TNFa has been shown [36]. The autocrine function of TNFa can
produce a feed-forward loop in which the release of inflammatory
mediators can be sustained for long periods of time [56]. Our
finding that TNFa protein levels were significantly increased
24 hours after intermittent stimulation supports this viewpoint.
Thus, TNFa overexpression (from exogenous injection or elicited
by intermittent stimulation) may engage such an autoregulatory
signaling loop that perpetuates TNFa activity and generates a long-
term metaplastic inhibition of spinal learning. This is a topic of
ongoing studies.
Therapeutic Potential for TNFa inhibition
At normal physiological levels, TNFa has been shown to play an
important role in regulating synaptic homeostasis [9]. It is in
response to neural insult or immune challenge that TNFa
overexpression can occur, causing an inflammatory response that
may undermine proper neural functioning. The inhibition of
TNFa has recently gained attention as an important tool in
fighting a number of inflammatory processes, as a number of
TNFa inhibitors (infliximab, etanercept, and adalimumab) are
currently indicated for the treatment of arthritis and psoriasis [57].
Further research is expanding the role of TNFa inhibition as
a therapy, as it has been shown that selectively ablating TNFa
receptors can attenuate dopaminergic neurotoxicity, a major
neural consequence believed to underlie the development of
Parkinson’s disease [58,59]. While TNFR1 signaling has been
characterized as inducing pro-inflammatory effects, the other TNF
receptor subtype, TNFR2, has been shown to mediate anti-
inflammatory, protective processes after neural insult. Under
normal physiological conditions, TNFR1 is constitutively ex-
pressed in a number of cell types throughout the spinal cord, while
TNFR2 is largely restricted to hematopoietic and endothelial cells
[60,61]. Following spinal cord injury, both receptor types are
upregulated in neurons, astrocytes, and oligodendrocytes [62].
While TNFR1 signaling after injury has been implicated in
mediating a number of deleterious processes that undermine
recovery, it has been suggested that the upregulation of TNFR2
after SCI may reflect a compensatory, protective response [63].
Although current ELISA technology does not differentiate
between soluble and membrane-bound forms of TNF, it is most
likely that the deleterious effects on spinal learning are due to
primarily to activation of the TNFR1 by soluble TNF, as we
demonstrate that exogenous soluble TNF is sufficient to un-
dermine spinal learning, and treatment with a soluble TNFR1
(which sequesters and inhibits available TNF) protects against
these effects.
After SCI, TNFa expression levels increase rapidly, peaking
within 2–6 hours, and slowly returning to baseline across the next
72 hours [41]. Thus, within this window when the spinal
microenvironement is extremely vulnerable, the threat of TNF
contributing to maladaptive spinal plasticity, as well as excitotoxi-
city, is high. We have recently shown that blocking TNFa activity
with sTNFR1 after spinal contusion injury significantly reduces
the trafficking of calcium permeable AMPARs to synaptic
membranes, and attenuated exitotoxic cell death [6]. For spinal
cord injury in the natural environment, the possibility for TNF
overexpression is compounded by the likelihood of concomitant
noxious input from other injuries sustained during traumatic spinal
cord injury (i.e. lacerations, broken bones, etc; [25]). The
intermittent stimulation used in our spinal plasticity paradigm
models the peripheral nociceptive input that may accompany
a spinal cord injury, and to this end, we have demonstrated that
intermittent stimulation after an experimental spinal contusion
injury creates a lasting deficit in locomotor recovery [17]. Recent
work has demonstrated that TNFa is a key mediator of nociceptive
plasticity [11,12,64,65]. The current findings suggest that noci-
ceptive plasticity (induced by intermittent stimulation) is a TNF-
mediated process that has a metaplastic effect on future adaptive
spinal modifications. As such, therapies that quell the over-
expression of TNFa may encourage recovery of function not only
by blocking nociceptive plasticity, but by reinstating the capacity
for adaptive plasticity. The benefits of promoting adaptive
plasticity in the injured spinal cord have been made evident in
recent animal studies, as well as a promising human case study
[14,66]. By resolving neurobiological impediments to adaptive
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receptive to positive change, and effective rehabilitation strategies
can be realized.
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